How To Get Online Basal Cell Carcinoma Treatment

Basal cell carcinoma is the most common form of skin cancer, and when caught early, it is highly treatable — but knowing which treatment is right for you, and how to get started, can feel overwhelming without a clear roadmap.

What is basal cell carcinoma

Basal cell carcinoma (BCC) is a cancer that starts in the basal cells — the cells at the bottom of the skin's outer layer (epidermis) that produce new skin cells as old ones die. BCC grows slowly and rarely spreads to other organs, but if left untreated, it can destroy surrounding tissue, nerves, and even bone. It most often appears on sun-exposed areas like the face, nose, ears, scalp, neck, and arms, though it can develop anywhere on the body.

A skin biopsy — where a small tissue sample is removed and examined in a lab — is required to confirm the diagnosis and identify the histologic subtype (the specific cell pattern). The subtype matters because it directly determines which treatment your doctor will recommend. When found early, basal cell skin cancer is highly curable.

Basal cell carcinoma treatment options

There is no single best treatment for every BCC. The right choice depends on the tumor's size, location, subtype, and whether it has returned after a previous treatment. Most options are outpatient procedures performed under local anesthesia. Here is what the evidence supports.

Mohs surgery versus standard excision

Mohs micrographic surgery (MMS) is considered the gold standard for treating high-risk [1] basal cell carcinoma. The surgeon removes the tumor one thin layer at a time, examining each layer under a microscope on-site until no cancer cells remain at the margins. This approach is preferred for BCC on the face — especially the nose, eyelids, ears, and lips — as well as for large tumors, aggressive subtypes (morpheaform, infiltrative, micronodular, basosquamous), recurrent tumors, and any location where preserving healthy tissue matters most.

Standard surgical excision removes the tumor along with a surrounding margin of healthy skin, which is then sent to an off-site lab. It is appropriate for low-risk, well-defined BCC on the trunk or extremities. Per clinical data, Mohs offers the lowest recurrence rates [2] of any BCC treatment, and the advantage over standard excision is most pronounced for high-risk and recurrent tumors [3]. For low-risk tumors with adequate margins, excision performs comparably. Both are outpatient procedures done under local anesthesia.

Curettage and electrodesiccation

Curettage and electrodesiccation (C&E) — also called electrosurgery — involves scraping the tumor with a curette [4] (a sharp, spoon-shaped instrument) and then applying an electric needle to destroy any remaining cancer cells and control bleeding. The process may be repeated during the same visit. C&E is best suited for small, well-defined, low-risk BCC on the trunk [5] or limbs. It is generally not recommended as a first-line option for facial BCC, where recurrence rates are higher and cosmetic outcomes less predictable.

Topical medications for superficial basal cell carcinoma

Two FDA-approved topical treatments are available for superficial BCC: imiquimod (an immune-response modifier [6] that activates the body's immune system to attack cancer cells) and topical 5-fluorouracil (a chemotherapy cream [7] that kills cancer cells directly). Both are applied to the skin over a course of several weeks. They are appropriate only for biopsy-confirmed superficial BCC in select locations, and clearance rates are generally lower than surgical options — making careful follow-up essential after treatment.

The decision to use topical therapy instead of surgery is always made by a licensed physician based on your specific biopsy findings and clinical factors. Lotus AI can help you understand whether your subtype may be a candidate for topical treatment and can facilitate a care plan with physician review — but prescriptions are only issued when clinically appropriate.

Cryosurgery, radiation, and other non-surgical options

Several additional treatments are available for specific situations:

• Cryosurgery: Liquid nitrogen is applied to freeze and destroy cancer cells. It may be an option for small, superficial BCC when surgery is not feasible, though recurrence risk is generally higher [8] than with surgical approaches.

• Radiation therapy: Focused energy beams are delivered over multiple sessions [9] — typically several weeks — to destroy cancer cells without cutting. It is primarily used for patients who cannot undergo surgery, elderly patients, or tumors in surgically difficult locations. It may also be used after surgery if margins are unclear.

• Photodynamic therapy (PDT): A light-sensitizing agent is applied to the skin, then activated by a specific light source to destroy cancer cells. PDT is limited to superficial BCC and is not recommended for invasive tumors.

• Laser surgery: Not FDA-approved as a primary BCC treatment, but sometimes used as a secondary option when other approaches have not been successful.

Targeted therapy and immunotherapy for advanced BCC

In rare cases where BCC is locally advanced — meaning it has grown deeply, recurred multiple times, or spread to other parts of the body — oral targeted therapies called Hedgehog pathway inhibitors may be used. Vismodegib and sonidegib [10] are both FDA-approved oral medications that block the molecular signaling pathway responsible for driving BCC growth. These are not first-line treatments for typical BCC; they are reserved for advanced cases [11] where surgery and radiation are not viable options.

An immunotherapy called cemiplimab is also approved [12] for advanced BCC in patients who have previously been treated with a Hedgehog pathway inhibitor or for whom one is not appropriate. Women who are pregnant or may become pregnant should not use Hedgehog inhibitors [13] — confirm all eligibility details and risks with your treating physician.

What can be done online versus in person

This is the most practical question for anyone who has just received a BCC diagnosis or suspects they may have one. Here is an honest breakdown.

What Lotus AI can do online — free, 24/7:

• Review and explain biopsy results: Upload your pathology report and Lotus AI can help you understand your subtype and what it means for treatment.

• Assess photos of a suspicious spot: Share images for initial triage, though a biopsy is always required for a definitive diagnosis.

• Build a personalized care plan: Based on your health records, biopsy findings, and clinical guidelines, Lotus AI outlines evidence-based next steps.

• Refer to the right specialist: Lotus AI can connect you with a dermatologist or Mohs surgeon and prepare your records so the in-person visit is more efficient from day one.

• Prescribe select topical medications when clinically appropriate: For biopsy-confirmed superficial BCC where a licensed Lotus AI physician determines topical treatment is suitable. Prescriptions and referrals are issued when appropriate, reviewed by licensed physicians.

• Coordinate follow-up and monitoring: Post-treatment check-ins, wound-healing guidance, and reminders for surveillance appointments.

What requires an in-person visit:

• Skin biopsy: A tissue sample must be physically collected and sent to a lab — this cannot be done virtually.

• Mohs surgery, excision, C&E, and cryosurgery: All require a dermatologist or surgeon in a clinical setting.

• Radiation therapy: Delivered in a radiation oncology facility over multiple sessions.

• Comprehensive skin exams: Full-body skin checks require in-person evaluation.

Even for steps that must happen in person, Lotus AI helps by triaging your situation, unifying your records so the specialist has the full picture on the first visit, and reducing the delays that come from fragmented care.

How Lotus AI moves you from diagnosis to treatment

Getting from a suspicious spot to the right treatment does not have to take months. Here is how the process works with Lotus AI:

1. Today: Open Lotus AI, upload photos of the lesion or your biopsy report, and answer a few health-history questions.

2. Within 24–48 hours: Receive a personalized care plan. Your AI doctor explains your subtype, outlines treatment options based on clinical guidelines, and provides a referral to a dermatologist or Mohs surgeon if a procedure is needed.

3. Before your in-person visit: Lotus AI prepares a unified health summary — records, medications, allergies, and relevant history — so your specialist has everything on the first visit. No repeated paperwork, no missing fragments.

4. After treatment: Lotus AI monitors your recovery, sends follow-up reminders, and flags any concerns that need attention.

Lotus AI is a free primary care practice — an AI doctor powered by real physicians from institutions including UC Davis Health, UCSF, Stanford Medicine, and Harvard Medical School. It is available 24/7 in over 50 languages, with no insurance required. Unlike a symptom checker or a general AI chatbot, Lotus AI is a licensed medical practice where clinicians are accountable for clinical decisions.

Follow-up care and skin cancer prevention after treatment

After BCC treatment, regular skin exams with a dermatologist are essential. People who have had one basal cell carcinoma are at elevated risk of developing another [14] — either at the same site or elsewhere. Your follow-up schedule will depend on the tumor's risk level and the treatment used; confirm the recommended intervals with your treating physician.

For prevention, the following steps reduce your risk of new BCC and support long-term skin health:

• Daily broad-spectrum sunscreen [15] (SPF 30 or higher) on all exposed skin

• Protective clothing including wide-brimmed hats and UV-blocking fabrics

• Avoiding peak UV hours [16] (typically 10 a.m. to 4 p.m.)

• Monthly self-skin-exams to check [17] for new or changing spots

• Annual professional skin checks [18] with a dermatologist

Lotus AI can send proactive reminders for follow-up appointments and help you track any new or changing skin spots between visits — working in the background so nothing falls through the cracks.

When to go to urgent care or the ER

Most BCC situations are not emergencies, but some signs warrant same-day care:

• A wound that is bleeding uncontrollably or shows signs of infection — increasing redness, warmth, swelling, pus, or fever — after a procedure

• Rapid growth or a significant change in a known lesion over days

• Vision changes or eye pain near a BCC site on or around the eyelid

• Severe reactions to topical medications, such as widespread blistering or systemic symptoms

In any of these situations, Lotus AI can assess your symptoms and route you to urgent care or the ER — but it is not the solution for emergencies. Think of it as triage: it helps you decide whether you need same-day care and prepares a summary for the emergency provider.

This article is for educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional for decisions about your care. Lotus AI provides evidence-based guidance with physician oversight and arranges in-person care when needed. Prescriptions and referrals issued when appropriate, reviewed by licensed physicians.